Clinical Trial Update: Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study of lithium in combination with oxaliplatin and capecitabine for advanced esophago-gastric or colorectal cancer has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lithium carbonate (Lithium carbonate)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Colorectal Neoplasms, Stomach Neoplasm | Phase 1 | Status: TERMINATED